Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Edgewise Therapeutics, Inc.(EWTX) | 15,021,721 | 15,021,721 | 0 | $270.54M | $400.93M | 7.34% | +$130.39M |
| Sinovac Biotech, Ltd.SHS(SVA) | 2,718,735 | 2,718,735 | 0 | $340.00M | $340.00M | 6.22% | $0 |
| Eli Lilly and Company(LLY) | 337,600 | 337,600 | 0 | $305.66M | $299.09M | 5.47% | -$6.56M |
| Boston Scientific Corporation(BSX) | 3,273,000 | 3,273,000 | 0 | $252.05M | $274.28M | 5.02% | +$22.22M |
| Intuitive Surgical, Inc.(ISRG) | 493,100 | 433,800 | -59,300 | $219.36M | $213.11M | 3.90% | -$6.24M |
| Enliven Therapeutics Inc | 7,959,538 | 7,959,538 | 0 | $186.01M | $203.29M | 3.72% | +$17.27M |
| Biogen Inc.(BIIB) | 900,900 | 813,000 | -87,900 | $208.85M | $157.59M | 2.88% | -$51.25M |
| Merck & Co., Inc.(MRK) | 1,316,000 | 1,316,000 | 0 | $162.92M | $149.44M | 2.73% | -$13.48M |
| Tenet Healthcare Corporation(THC) | 1,173,300 | 782,000 | -391,300 | $156.08M | $129.97M | 2.38% | -$26.12M |
| Stryker Corporation(SYK) | 269,000 | 344,400 | +75,400 | $91.53M | $124.42M | 2.28% | +$32.89M |
| ARS Pharmaceuticals, Inc.(SPRY) | 9,240,887 | 8,288,510 | -952,377 | $78.64M | $120.18M | 2.20% | +$41.54M |
| Sarepta Therapeutics, Inc.(SRPT) | 646,000 | 954,500 | +308,500 | $102.07M | $119.21M | 2.18% | +$17.14M |
| argenx SEADR(ARGX) | 209,100 | 204,500 | -4,600 | $89.92M | $110.86M | 2.03% | +$20.93M |
| UnitedHealth Group Incorporated(UNH) | 112,000 | 179,000 | +67,000 | $57.04M | $104.66M | 1.92% | +$47.62M |
| Q32 Bio Inc.(QTTB) | 2,252,987 | 2,252,987 | 0 | $40.44M | $100.53M | 1.84% | +$60.09M |
| MBX Biosciences, Inc.(MBX) | 0 | 3,812,215 | +3,812,215 | $0 | $99.04M | 1.81% | +$99.04M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,372,333 | 2,324,447 | -47,886 | $113.07M | $93.12M | 1.70% | -$19.95M |
| Disc Medicine, Inc.(IRON) | 1,785,571 | 1,785,571 | 0 | $80.48M | $87.74M | 1.61% | +$7.27M |
| Natera, Inc.(NTRA) | 687,500 | 687,500 | 0 | $74.45M | $87.28M | 1.60% | +$12.83M |
| Amgen Inc.(AMGN) | 134,900 | 252,300 | +117,400 | $42.15M | $81.29M | 1.49% | +$39.14M |
| Third Harmonic Bio Inc | 5,779,071 | 5,779,071 | 0 | $75.13M | $78.31M | 1.43% | +$3.18M |
| Integer Holdings Corporation(ITGR) | 349,221 | 575,000 | +225,779 | $40.44M | $74.75M | 1.37% | +$34.31M |
| ArriVent BioPharma, Inc.(AVBP) | 3,027,328 | 3,027,328 | 0 | $56.16M | $71.14M | 1.30% | +$14.99M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 151,000 | 151,000 | 0 | $70.78M | $70.23M | 1.29% | -$549.6K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 250,300 | 250,300 | 0 | $60.82M | $68.84M | 1.26% | +$8.02M |
| Terns Pharmaceuticals Inc | 7,619,135 | 7,562,971 | -56,164 | $51.89M | $63.08M | 1.15% | +$11.19M |
| Keros Therapeutics, Inc.(KROS) | 1,268,734 | 1,018,734 | -250,000 | $57.98M | $59.16M | 1.08% | +$1.18M |
| Janux Therapeutics, Inc.(JANX) | 2,979,828 | 1,258,566 | -1,721,262 | $124.82M | $57.18M | 1.05% | -$67.65M |
| Elevance Health, Inc.(ELV) | 168,100 | 106,200 | -61,900 | $91.09M | $55.22M | 1.01% | -$35.86M |
| Crinetics Pharmaceuticals In | 1,280,800 | 1,050,055 | -230,745 | $57.37M | $53.66M | 0.98% | -$3.71M |
| Thermo Fisher Scientific Inc.(TMO) | 132,000 | 84,400 | -47,600 | $73.00M | $52.21M | 0.96% | -$20.79M |
| Xtant Medical Holdings, Inc.(XTNT) | 73,114,592 | 73,114,592 | 0 | $46.06M | $49.43M | 0.90% | +$3.36M |
| Avidity Biosciences Inc | 706,475 | 1,044,805 | +338,330 | $28.86M | $47.99M | 0.88% | +$19.13M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 22,800 | 45,200 | +22,400 | $23.96M | $47.52M | 0.87% | +$23.55M |
| Evolent Health, Inc.CL A(EVH) | 2,605,615 | 1,665,115 | -940,500 | $49.82M | $47.09M | 0.86% | -$2.73M |
| Endeavour Silver Corp.(EXK) | 672,416 | 679,816 | +7,400 | $28.41M | $46.31M | 0.85% | +$17.90M |
| SI-BONE, Inc.(SIBN) | 3,229,977 | 3,305,801 | +75,824 | $41.76M | $46.22M | 0.85% | +$4.45M |
| Springworks Therapeutics Inc | 1,707,331 | 1,390,631 | -316,700 | $64.32M | $44.56M | 0.82% | -$19.76M |
| Vaxcyte, Inc.(PCVX) | 795,900 | 387,000 | -408,900 | $60.10M | $44.22M | 0.81% | -$15.88M |
| Compass Therapeutics, Inc.(CMPX) | 22,362,850 | 22,362,850 | 0 | $22.36M | $41.15M | 0.75% | +$18.78M |
| Cytokinetics, Incorporated(CYTK) | 812,906 | 766,906 | -46,000 | $44.04M | $40.49M | 0.74% | -$3.55M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,925,300 | 1,925,300 | 0 | $39.53M | $37.06M | 0.68% | -$2.46M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 6,943,654 | 6,943,654 | 0 | $12.64M | $36.66M | 0.67% | +$24.03M |
| Apellis Pharmaceuticals Inc COM | 1,302,800 | 1,270,400 | -32,400 | $49.98M | $36.64M | 0.67% | -$13.34M |
| Xenon Pharmaceuticals Inc.(XENE) | 862,362 | 911,420 | +49,058 | $33.62M | $35.88M | 0.66% | +$2.26M |
| Universal Health Services, Inc.CL B(UHS) | 0 | 156,000 | +156,000 | $0 | $35.73M | 0.65% | +$35.73M |
| ICON Public Limited CompanySHS(ICLR) | 174,100 | 123,900 | -50,200 | $54.58M | $35.60M | 0.65% | -$18.98M |
| Neurocrine Biosciences, Inc.(NBIX) | 448,200 | 302,220 | -145,980 | $61.70M | $34.82M | 0.64% | -$26.88M |
| Vera Therapeutics, Inc.CL A(VERA) | 675,872 | 675,872 | 0 | $24.45M | $29.87M | 0.55% | +$5.42M |
| BioAge Labs, Inc.(BIOA) | 0 | 1,423,470 | +1,423,470 | $0 | $29.61M | 0.54% | +$29.61M |
| Scpharmaceuticals Inc | 5,559,528 | 6,059,528 | +500,000 | $24.18M | $27.63M | 0.51% | +$3.45M |
| Vir Biotechnology, Inc.(VIR) | 2,320,102 | 3,573,000 | +1,252,898 | $20.65M | $26.76M | 0.49% | +$6.11M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 1,449,073 | +1,449,073 | $0 | $26.20M | 0.48% | +$26.20M |
| CG Oncology, Inc.(CGON) | 0 | 691,114 | +691,114 | $0 | $26.08M | 0.48% | +$26.08M |
| Dyne Therapeutics, Inc.(DYN) | 708,400 | 708,400 | 0 | $25.00M | $25.45M | 0.47% | +$446.3K |
| C4 Therapeutics, Inc.(CCCC) | 1,513,058 | 4,377,900 | +2,864,842 | $6.99M | $24.95M | 0.46% | +$17.96M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,021,424 | 2,002,939 | -18,485 | $23.65M | $24.26M | 0.44% | +$604.9K |
| NeuroPace, Inc.(NPCE) | 3,406,335 | 3,406,335 | 0 | $25.75M | $23.74M | 0.43% | -$2.01M |
| Immatics N.V.SHS(IMTX) | 2,006,381 | 2,006,381 | 0 | $23.31M | $22.89M | 0.42% | -$421.3K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 704,842 | 435,900 | -268,942 | $28.94M | $22.84M | 0.42% | -$6.10M |
| Ikena Oncology IncNONVOTING | 12,048,773 | 12,048,773 | 0 | $32.15M | $22.78M | 0.42% | -$9.37M |
| Prelude Therapeutics Incorporated(PRLD) | 10,909,256 | 10,909,256 | 0 | $41.56M | $22.58M | 0.41% | -$18.98M |
| Apogee Therapeutics Inc | 379,130 | 379,130 | 0 | $14.92M | $22.27M | 0.41% | +$7.35M |
| Neumora Therapeutics, Inc.(NMRA) | 1,500,000 | 1,500,000 | 0 | $14.74M | $19.82M | 0.36% | +$5.07M |
| Acelyrin Inc | 4,001,711 | 4,001,711 | 0 | $17.65M | $19.73M | 0.36% | +$2.08M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 912,552 | +912,552 | $0 | $18.83M | 0.34% | +$18.83M |
| Tyra Biosciences, Inc.(TYRA) | 768,638 | 768,638 | 0 | $12.29M | $18.07M | 0.33% | +$5.78M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,147,655 | 1,070,055 | -77,600 | $20.02M | $17.91M | 0.33% | -$2.10M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 5,846,100 | 11,024,000 | +5,177,900 | $9.82M | $17.31M | 0.32% | +$7.49M |
| Structure Therapeutics IncADS | 125,000 | 383,705 | +258,705 | $4.91M | $16.84M | 0.31% | +$11.93M |
| Adicet Bio Inc | 11,447,140 | 11,447,140 | 0 | $13.85M | $16.48M | 0.30% | +$2.63M |
| Medpace Holdings, Inc.(MEDP) | 0 | 44,900 | +44,900 | $0 | $14.99M | 0.27% | +$14.99M |
| ADC Therapeutics SASHS(ADCT) | 4,316,824 | 4,533,801 | +216,977 | $13.64M | $14.28M | 0.26% | +$640.3K |
| Gilead Sciences, Inc.(GILD) | 0 | 151,700 | +151,700 | $0 | $12.72M | 0.23% | +$12.72M |
| BioNTech SEADS(BNTX) | 0 | 103,000 | +103,000 | $0 | $12.23M | 0.22% | +$12.23M |
| Acadia Pharmaceuticals Inc | 0 | 764,600 | +764,600 | $0 | $11.76M | 0.22% | +$11.76M |
| Repare Therapeutics Inc | 3,322,488 | 3,322,488 | 0 | $10.96M | $11.43M | 0.21% | +$465.1K |
| AbCellera Biologics Inc.(ABCL) | 4,180,768 | 4,180,768 | 0 | $12.38M | $10.87M | 0.20% | -$1.51M |
| PMV Pharmaceuticals, Inc.(PMVP) | 6,475,291 | 6,475,291 | 0 | $10.49M | $9.65M | 0.18% | -$841.8K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 967,000 | +967,000 | $0 | $9.19M | 0.17% | +$9.19M |
| Verastem, Inc.(VSTM) | 1,529,115 | 2,862,448 | +1,333,333 | $4.56M | $8.56M | 0.16% | +$4.00M |
| Lyell Immunopharma, Inc.(LYEL) | 6,405,098 | 6,086,001 | -319,097 | $9.29M | $8.40M | 0.15% | -$888.7K |
| Oscar Health, Inc.CL A(OSCR) | 0 | 351,618 | +351,618 | $0 | $7.46M | 0.14% | +$7.46M |
| Bicara Therapeutics Inc | 0 | 271,910 | +271,910 | $0 | $6.93M | 0.13% | +$6.93M |
| Passage Bio, Inc.(PASG) | 10,124,576 | 9,822,876 | -301,700 | $8.04M | $6.88M | 0.13% | -$1.16M |
| PepGen Inc.(PEPG) | 0 | 797,358 | +797,358 | $0 | $6.82M | 0.12% | +$6.82M |
| Nkarta, Inc.(NKTX) | 800,000 | 1,480,600 | +680,600 | $4.73M | $6.69M | 0.12% | +$1.96M |
| Ikena Oncology Inc | 3,539,358 | 3,539,358 | 0 | $5.84M | $6.12M | 0.11% | +$283.1K |
| Amicus Therapeutics Inc COM | 570,300 | 570,300 | 0 | $5.66M | $6.09M | 0.11% | +$433.4K |
| Scholar Rock Holding Corporation(SRRK) | 1,074,382 | 742,300 | -332,082 | $8.95M | $5.95M | 0.11% | -$3.00M |
| Fate Therapeutics, Inc.(FATE) | 1,355,352 | 1,680,580 | +325,228 | $4.45M | $5.88M | 0.11% | +$1.44M |
| InspireMD, Inc.(NSPR) | 2,133,405 | 2,133,405 | 0 | $5.32M | $5.72M | 0.10% | +$394.0K |
| Longboard Pharmaceuticals In | 0 | 170,000 | +170,000 | $0 | $5.67M | 0.10% | +$5.67M |
| TELA Bio, Inc.(TELA) | 2,457,542 | 2,161,185 | -296,357 | $11.55M | $5.47M | 0.10% | -$6.08M |
| X4 Pharmaceuticals, Inc.(XFOR) | 7,133,515 | 7,133,515 | 0 | $4.14M | $4.77M | 0.09% | +$637.0K |
| Krystal Biotech, Inc.(KRYS) | 29,966 | 23,500 | -6,466 | $5.50M | $4.28M | 0.08% | -$1.23M |
| Ardent Health, Inc.(ARDT) | 0 | 206,000 | +206,000 | $0 | $3.79M | 0.07% | +$3.79M |
| Traws Pharma, Inc.(TRAW) | 0 | 605,531 | +605,531 | $0 | $3.56M | 0.07% | +$3.56M |
| Milestone Pharmaceuticals Inc.(MIST) | 2,000,000 | 2,000,000 | 0 | $2.64M | $3.04M | 0.06% | +$400.0K |
| Chemomab Therapeutics LtdADS | 2,241,273 | 1,741,273 | -500,000 | $2.05M | $2.73M | 0.05% | +$688.6K |